Inventor · disambiguated record
Paul Ponath
Also filed as: PONATH PAUL · PONATH PAUL D · PONATH PAUL DAVID
36 granted patents·24 pending applications·1,727 citations·filing 1995–2025
98Inventor score
Files withMILLENNIUM PHARM INC17GITR INC7BRISTOL MYERS SQUIBB CO5KENJOCKETY BIOTECHNOLOGY INC4MERCK SHARP & DOHME4
Top patents by PatentIndex Score
60 records- 0197US8591886B2Combination therapies employing GITR binding moleculesPONATH PAUL·Filed 2008·Granted Nov 26, 2013·399 cites·10 claims
- 0296US9028823B2Methods of inducing or enhancing an immune response in a subject by administering agonistic GITR binding antibodiesGITR INC·Filed 2013·Granted May 12, 2015·77 cites·20 claims
- 0396US8388967B2Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodiesSMITH L MARY·Filed 2010·Granted Mar 5, 2013·422 cites·34 claims
- 0496US7812135B2GITR-binding antibodiesTOLERRX INC·Filed 2006·Granted Oct 12, 2010·450 cites·27 claims
- 0596US7053202B2Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use thereforMILLENNIUM PHARM INC·Filed 2002·Granted May 30, 2006·62 cites·37 claims
- 0694US9241992B2Combination therapies employing GITR binding moleculesGITR INC·Filed 2013·Granted Jan 26, 2016·22 cites·19 claims
- 0791US7777008B2ILT3 binding molecules and uses thereforTOLERX INC·Filed 2007·Granted Aug 17, 2010·19 cites·28 claims
- 0891US7147851B1Humanized immunoglobulin reactive with α4β7 integrinMILLENNIUM PHARM INC·Filed 1996·Granted Dec 12, 2006·83 cites·9 claims
- 0990US9493572B2GITR antibodies and methods of inducing or enhancing an immune responseGITR INC·Filed 2015·Granted Nov 15, 2016·7 cites·21 claims
- 1090US7402410B2Humanized immunoglobulin reactive with α4β7 integrinMILLENNIUM PHARM INC·Filed 2006·Granted Jul 22, 2008·12 cites·23 claims
- 1187US8901281B2ILT3 binding molecules and uses thereforPONATH PAUL·Filed 2006·Granted Dec 2, 2014·13 cites·22 claims
- 1287US6936248B1Methods of inhibiting GPR-9-6 functionMILLENNIUM PHARM INC·Filed 2000·Granted Aug 30, 2005·22 cites·71 claims
- 1385US6689570B2Methods of identifying agents which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·50 claims
- 1483US7381412B2Anti-TECK antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2005·Granted Jun 3, 2008·4 cites·4 claims
- 1582US6884574B2Methods of identifying agents which inhibit GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Apr 26, 2005·12 cites·35 claims
- 1680US6329159B1Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 functionMILLENNIUM PHARM INC·Filed 1999·Granted Dec 11, 2001·30 cites·43 claims
- 1780US2025361313A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1879US8753828B2Humanized anti-CCR2 antibodies and methods of use thereforO'KEEFE THERESA·Filed 2010·Granted Jun 17, 2014·4 cites·9 claims
- 1978US7423129B2Antibodies to human eotaxinMILLENNIUM PHARM INC·Filed 2007·Granted Sep 9, 2008·1 cites·10 claims
- 2077US2024228642A9Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2176US10030074B2Methods of inducing or enhancing an immune response in a subject having cancer by administering GITR antibodiesGITR INC·Filed 2016·Granted Jul 24, 2018·1 cites·21 claims
- 2276US6537764B1Method of identifying inhibitors of C—C chemokine receptor 3CHILDRENS MEDICAL CENTER·Filed 1996·Granted Mar 25, 2003·28 cites·83 claims
- 2372US7012133B1Antibodies to C-C chemokine Receptor 3 ProteinBRIGHAM & WOMENS HOSPITAL·Filed 1997·Granted Mar 14, 2006·22 cites·149 claims
- 2471US8846397B2Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragmentsAPOSTOLOU IRINA·Filed 2011·Granted Sep 30, 2014·3 cites·22 claims
- 2571US7485301B2Methods of treating inflammatory disease using antibodies which bind GPR-9-6MILLENNIUM PHARM INC·Filed 2001·Granted Feb 3, 2009·3 cites·19 claims
- 2669US7858326B2Method of diagnosis of inflammatory disease using eotaxin antibodiesMILLENNIUM PHARM INC·Filed 2008·Granted Dec 28, 2010·0 cites·7 claims
- 2769US2021363267A1Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2866US10570209B2Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodiesGITR INC·Filed 2018·Granted Feb 25, 2020·0 cites·22 claims
- 2965US9353184B2Humanized anti-CCR2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2014·Granted May 31, 2016·0 cites·8 claims
- 3065US2009012269A1Humanized anti-ccr2 antibodies and methods of use thereforMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 3164US11104739B2Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibodyBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 31, 2021·0 cites·17 claims
- 3263US9534051B2Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragmentsMERCK SHARP & DOHME·Filed 2014·Granted Jan 3, 2017·0 cites·15 claims
- 3363US2009068188A1C-C chemokine receptor 3 proteinsGERARD CRAIG J·Filed 2008·Application pending·0 cites
- 3462US7265201B1Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 1995·Granted Sep 4, 2007·8 cites·5 claims
- 3562US2009011464A1Humanized immunoglubulin reactive with alph4beta7 integrinMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 3660US7285620B2Human chemotactic cytokineMILLENNIUM PHARM INC·Filed 2005·Granted Oct 23, 2007·0 cites·18 claims
- 3759US7402657B2C-C chemokine receptor 3 proteinsMILLENNIUM PHARM INC·Filed 2005·Granted Jul 22, 2008·0 cites·16 claims
- 3859US2019030162A1Combination Therapies Employing GITR Binding MoleculesGITR INC·Filed 2018·Application pending·0 cites
- 3958US2015139986A1Ilt3 binding molecules and uses thereforMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4057US2004151721A1Humanized anti-CCR2 antibodies and methods of use thereforFiled 2003·Application pending·0 cites
- 4153US6994977B2Method of identifying inhibitors of C—C chemokine receptor 3BRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Feb 7, 2006·0 cites·95 claims
- 4253US2016324963A1Combination therapies employing gitr binding moleculesGITR INC·Filed 2015·Application pending·0 cites
- 4351US2008112949A1Optimized dosing with anti-CD4 antibodies for tolerance induction in primatesTOLERX INC·Filed 2007·Application pending·0 cites
- 4450US2006147445A1Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use thereforO'KEEFE THERESA·Filed 2005·Application pending·0 cites
- 4549US9828425B2Anti-ILT5 antibodies and ILT5-binding antibody fragmentsMERCK SHARP & DOHME·Filed 2015·Granted Nov 28, 2017·0 cites·20 claims
- 4649US6806061B1G protein-coupled receptor gene and methods of use thereforCHILDRENS MEDICAL CENTER·Filed 1995·Granted Oct 19, 2004·6 cites·87 claims
- 4747US9023997B2Anti-ILT5 antibodies and ILT5-binding antibody fragmentsAPOSTOLOU IRINA·Filed 2011·Granted May 5, 2015·0 cites·22 claims
- 4847US2017158765A1Immunoregulation by anti-ilts antibodies and ilts-binding antibody fragmentsMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4947US2023272117A1Anti abcc1 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 5047US2025051471A1Anti-Abcb1 AntibodiesWILLIAM ROBERT ARATHOON LIVING TRUST DATED AUGUST 29 2016·Filed 2022·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →